News & Analysis as of

CARES Act Regulatory Reform

McDermott+

Looking Forward: Top Policy Areas for 2024

McDermott+ on

Happy New Year! As we enter 2024, we want to lay out some of the main regulatory issues (both new and old) that McDermott+Consulting will be tracking over the next year. While these may evolve, we think they are still...more

Best Best & Krieger LLP

In With the New – Part Six

BB&K’s New Law Guidance for a Well-Informed Start to 2023 - In Part Six of our “In With the New” series, Best Best & Krieger LLP covers important new legislation related to environmental matters, housing and public...more

Stinson - Benefits Notes Blog

IRS Extends Deadline For Plan Sponsors To Adopt Amendments Reflecting Recent Law Changes

On August 3, 2022, the IRS published Notice 2022-33, which extends the deadlines for amending retirement plans and IRAs to reflect certain changes to the law made by the SECURE Act; the Bipartisan American Miners Act; and...more

Ogletree, Deakins, Nash, Smoak & Stewart,...

Unemployment Insurance System Update, Part I: Is Comprehensive Reform Coming?

On April 28, 2021, President Joe Biden unveiled a proposal to permanently expand unemployment benefits in his most recent economic package, the American Families Plan. The proposed expansion of unemployment benefits is in...more

Williams Mullen

Environmental Notes - July 2020

Williams Mullen on

Two recent executive orders (“EOs”) issued by President Trump require additional efforts by federal agencies to facilitate regulatory reform and to expedite infrastructure projects, relying greatly on emergency and special...more

Troutman Pepper

CARES Act Reforms Monograph System For Over-The-Counter Drugs

Troutman Pepper on

Included in the CARES Act are long-awaited reforms to the FDA’s regulation of over-the-counter (OTC) medications. H.R. 748, §§ 3851-3862. The FDA has hailed the law as granting it “transformative, new authorities that will...more

ArentFox Schiff

Congress Enacts Sweeping Reforms to Over-the-Counter Drug Regulation as Part of COVID-19 Response Bill

ArentFox Schiff on

For years, regulators, industry, and lawmakers alike have sought to modernize the regulatory framework under which most over-the-counter (OTC) drugs are marketed in the US. With the enactment of the Coronavirus Aid, Relief,...more

Goodwin

U.S. CARES Act Enables Long-Awaited OTC Drug Regulatory Modernization: Key Highlights

Goodwin on

Subtitle F of the recently enacted U.S. CARES Act substantially reforms the regulatory framework for non-prescription drugs, representing the most significant update of the review process for over-the-counter (OTC) drugs...more

Hogan Lovells

At long last, landmark OTC Drug reform legislation is enacted

Hogan Lovells on

On March 27, 2020, as part of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), U.S. President Trump signed into law a long-awaited overhaul of the regulatory system for Over-the-Counter (OTC) drugs. ...more

9 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide